Sustained clinical responses to tyrosine kinase inhibitor sunitinib in thyroid carcinoma

Authors

Keywords

Journal

Volume 19, Issue 5, Pages 547-552

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2010-02-25

DOI

10.1097/cad.0b013e3282fc6cf7

Discuss science. Find collaborators. Network.

Join a conversation

Explore over 38,000 international journals covering a vast array of academic fields.